Memorial Sloan-Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT00578162
To describe the range of services available to cancer survivors in the NYC area.
To determine organizations' need for assistance to enhance services for survivors.
Looking for future studies?
Notify MeAll sexes
Observational
New York, 10065, United States
To describe the range of services available to cancer survivors in the NYC area.
To determine organizations' need for assistance to enhance services for survivors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.
A cancer care facility or 'agency' is the study's unit of analysis. Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory
Time frame: 2 years
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04316962
All Cancers, Cancer Survivors
Bergen, Vestland, Norway
View Trial DetailsNCT06863623
Chemotherapy Effect, Distress, Emotional
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07828028
Anxiety Disorders, Chemotherapy
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT01046487
Adenocarcinoma, Cancer
Bordeaux, France
View Trial Details